LAURA BRAY, MBA CHIEF CHANGE MAKER ANGELS FOR CHANGE
Laura Bray is the Founder and Chief Change Maker of Angels for Change, the only U.S. patient-led nonprofit singularly focused on ending drug shortages. Called the “Pharmaceutical Industry’s
Accidental Expert” by NPR, Laura has become one of the nation’s most respected and pragmatic leaders driving reform across healthcare supply chains.
What sets Laura apart is her rare combination of lived patient experience and business acumen. After her daughter Abby endured three life-saving chemotherapy drug shortages during pediatric
cancer treatment, Laura transformed personal crisis into systemic change. With a background in marketing strategy, small business consulting, and an MBA from the University of South Florida, she
approaches drug shortages not only as a patient advocate — but as a builder of market-based, scalable solutions.
Under her leadership, Angels for Change has supported facilities and patients through more than 130 unique drug shortage crises, helped secure access to over 800,000 shortage treatments during
supply disruptions, and operates the nation’s only drug shortages patient hotline. Laura has built the Global Supply Sharing Network, launched SummitONE — the only U.S. conference exclusively
dedicated to drug shortages — and co-founded the End Drug Shortage Alliance (EDSA), bringing together manufacturers, GPOs, health systems, regulators, and patient advocates to implement
practical, measurable solutions.
Laura is also the architect behind two groundbreaking initiatives:
Project Protect — a first-of-its-kind resilience model that creates predictable demand and supply stability for vulnerable generic sterile injectables on shore. Project Protect has been recognized
nationally as an innovative market-based approach to strengthening domestic manufacturing and safeguarding essential medicines. The initiative has received bipartisan praise and industry
accolades for demonstrating that aligning patient voice with procurement strategy can drive measurable supply chain resilience.
Project GOLD (Generic Oncology Lifesaving Drugs) — a targeted initiative focused on building on-shore buffer supply of critical oncology medications, ensuring that cancer patients never face
treatment delays due to fragile supply chains. Project GOLD leverages cross-sector collaboration, transparent data, trusted communications, and proactive strategies to protect the most vulnerable
patients.
Laura’s bold leadership has earned national recognition, including being named a 2023 Healthcare Champion by CNN. She has served on the White House drug shortages task force, testified before
Congress, and has been featured in more than 100 national media stories including The New York Times, The Wall Street Journal, Axios, STAT News, Fox News, and NPR.
Before founding Angels for Change in 2019, Laura served as an Adjunct Business Professor at Hillsborough Community College for nearly two decades, equipping future leaders with practical
business skills. Today, she applies that same disciplined, solutions-oriented mindset to one of healthcare’s most complex challenges.
Laura Bray is not only advocating for change — she is building it. Her work bridges patients, policymakers, and industry to create a resilient, accountable pharmaceutical supply chain so that no
patient ever hears the words, “We don’t have the medicine you need.”